Friday, April 21, 2023 1:29:11 PM
Transfer Agents that issue shares (restricted or free trading) do so at the companies or debt holder request. HOWEVER! Some transfer agents will not issue free trading shares on a debt conversion until after the debt holder shows they have paid the debt.
Schemers do NOT like to pay ONE PENNY out of pocket so they choose to use transfer agents that allow shares to be issued free trading on the debt conversion approval before the debt us actually paid. Those transfer agents are hand picked by the scheme before the ticker or reverse merger is in play.
Then the debt converters pay after they dump diluted shares so they are out no money up front. They pay the debt with investor’s money, and is a small fraction of what they rake in.
GNGR uses Pacific Stock Transfer and they require proof of debt payment before they release the free trading shares to the debt holders. And scheme debt holders stay CLEAR of those LEGIT transfer agents.
Since going public GNGR has survived while twice the listed OTC tickers since 2012 have traded hands, had name changes, ticker changes, or folded. People hate GNGR and that is good for us. We see things differently then what all retailers see.
Pump and dump retail investors see the pretty frosting on the cake even if the actual cake is cement. We see what the cake is made of before any frosting is put on it.
Those pump and dump schemes are like a cute Panda Bear, you want to reach out and pet it and when you do the bear rips your arm off.
GNGR is like a harmless turtle or un-frosted cake. But a turtle is not as cute as a Panda Bear but at least you won't get your arm ripped off. And no one likes un-frosted cake
The problem with retailers is they want the frosting over cement and to keep petting the Panda Bear. And the outcome is always the same.
Broken teeth and no more arms! :)
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM